Prevalent Decrease of the EGF Content in the Periurethral Zone of BPH Tissue Induced by Treatment with Finasteride or Flutamide

September 1997 in “ PubMed ”

Sara Monti, F. Sciarra, M.V. Adamo, Vincenzo Toscano, M. Trotta, Claudia Martini, S. Lanzara, Franco Di Silverio

We don't know much about this study yet.

We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.

View this study on pubmed.ncbi.nlm.nih.gov →

Discuss this study in the Community →

Cited in this study

2 / 2 results

research The Effect of Finasteride in Men with Benign Prostatic Hyperplasia

1040 citations , October 1992 in “The New England Journal of Medicine”

Finasteride effectively treats BPH but may increase sexual dysfunction risk.

research Three-Month Treatment With a Long-Acting Gonadotropin-Releasing Hormone Agonist of Patients With Benign Prostatic Hyperplasia: Effects on Tissue Androgen Concentration, 5α-Reductase Activity and Androgen Receptor Content*

82 citations , February 1989 in “The Journal of clinical endocrinology and metabolism/Journal of clinical endocrinology & metabolism”

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

2 / 2 results

research Prevalent Decrease of the EGF Content in the Periurethral Zone of BPH Tissue Induced by Treatment with Finasteride or Flutamide

7 citations , September 1997 in “PubMed”

research Effect of finasteride, a 5 alpha-reductase inhibitor, on serum gonadotropins in normal men.

30 citations , August 1992 in “The Journal of Clinical Endocrinology and Metabolism”

Finasteride doesn't affect hormone levels in normal men.